
Mission
The Vaccine Considerations Project has been created to highlight health and safety throughout the COVID-19 vaccine evaluation process.
Feb. 26th FDA Advisory Council (VRBPAC) Meeting
The FDA Vaccines and Related Biological Products Advisory Committee met on February 26th to consider the Emergency Use Authorization of the Johnson & Johnson (Janssen Biotech) COVID-19 vaccine.
Presentation #1
The Vaccine Considerations Project’s founder, Jared Krupnick, provided an oral presentation entitled “Preventing Health Inequities” at the FDA Vaccines and Related Biological Products Advisory Committee meeting on February 26th.
This was Jared’s second time presenting to the VRBPAC, having also presented when the Committee considered the Pfizer vaccine on December 10th.
Presentation #2
Our Senior Medical Advisor, Dr. David Berger, provided an oral presentation entitled “COVID-19 Vaccine Considerations Related to Pregnancy” at the FDA Vaccines and Related Biological Products Advisory Committee meeting on February 26th.
This was Dr. Berger’s third time presenting to the VRBPAC, having also presented when the Committee considered the Pfizer and Moderna vaccines on December 10th and 17th.
- Submitted written comments
- References
- Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
- KFF COVID-19 Vaccine Monitor: December 2020
- Why might women be less eager to get the coronavirus vaccine? An investigation.
- The W.H.O. drops opposition to vaccinations for pregnant women.
- References
- Presentation slides
- References
- COVID-19 Vaccine infographic for pregnant women
- Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
- KFF COVID-19 Vaccine Monitor: December 2020
- Why might women be less eager to get the coronavirus vaccine? An investigation.
- The Breadth of Viruses in Human Semen
- In Vivo Genetic Manipulation of Spermatogonial Stem Cells and Their Microenvironment by Adeno-Associated Viruses
- References
Dec. 17th FDA Advisory Council (VRBPAC) Meeting
Our Senior Medical Advisor, Dr. David Berger, again, provided an oral presentation at the FDA Vaccines and Related Biological Products Advisory Committee meeting at on December 17th – see the video.
Dec. 10th FDA Advisory Council (VRBPAC) Meeting
Both Jared Krupnick, the Founder of the Vaccine Considerations Project, as well as Board Certified Pediatrician, and the project’s Senior Medical Advisor, Dr. David Berger, were pleased to provide separate oral presentations (Jared’s presentation) (Dr. Berger’s presentation) to the FDA Vaccines and Related Biological Products Advisory Committee meeting on December 10th.
Leading the 6pm News in Miami / Ft. Lauderdale
See the very supportive news coverage we received of our presentations to the FDA Advisory Committee December 10th.
Dr. Berger Prominently Featured in Tampa Media
See the excellent news coverage our Senior Medical Advisor, Dr. Berger, received of his presentations to the FDA Advisory Committee December 10th (WFLA coverage) (WTSP coverage).
Vision
We’re working to make sure that all health and safety concerns are given due consideration.
We’re creating a repository of information for everyone contemplating getting a vaccine, and for those advising them, that comprehensively addresses health concerns and considerations.
Photo by Kon Karampelas from Pixabay
Public Trust is Necessary
In order to eliminate COVID-19, a large percentage of people need to develop immunity.
Significant vaccine hesitancy has been well documented, and reinforced by recent news.
Widespread concerns must be adequately addressed in order to ensure sufficient buy-in by:
- public health experts
- medical professionals
- the public
Additional Considerations
There may be unforeseen adverse reactions for the COVID vaccines that may emerge in people who have:
- hyperinflammatory conditions
- cancers
- people with poor health or nutrition
- past exposure/immunity to the COVID virus
The Stakes are High
With a high percentage of COVID-19 immunity amongst the population, we may return to a semblance of normalcy within a year or two.
If public trust is broken by an approved vaccine that develops health or safety concerns after being administered to millions of people, many people likely wouldn’t give a second chance to another vaccine.
Without widespread immunity, we could all be forced to live in a world upended by the community spread of COVID-19 for years to come.
The Vaccine Considerations Project
Organizing Collective Concerns
The Vaccine Considerations Project is consolidating, organizing, and amplifying collective COVID-19 vaccine health and safety concerns of:
- the medical community
- epidemiologists
- public health experts
- the community at large
Repository of Information
We’re making our repository of information available to:
- advisory panels
- national associations
- medical professionals
- researchers
- individuals
- the media
Photo by Kon Karampelas from Pixabay
Collective Action Required
We’re urging all concerned stakeholders to collectively contribute to, and share, a comprehensive repository of information that addresses health and safety concerns for the COVID vaccines.
It’s imperative that we urgently work together to ensure that any approved vaccine is safe.
All Hands on Deck
We’re recruiting all that align with this critical project.
Contribute your time and skills to help prevent catastrophic health conditions from arising.
See the positions we’re filling, and apply for an internship or position on our interdisciplinary team of students and professionals.